![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 48, 37462-37468, December 1, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
F508 Cystic Fibrosis
Transmembrane Conductance Regulator (CFTR)-Molecular Chaperone Complex
with Geldanamycin Stabilizes
F508 CFTR in the Rabbit
Reticulocyte Lysate*
and
From the Department of Pharmacology, University of Cambridge,
Tennis Court Road, Cambridge CB2 1QJ, United Kingdom
The
F508 mutation of cystic fibrosis
transmembrane conductance regulator (CFTR) is a trafficking
mutant, which is retained and degraded in the endoplasmic
reticulum by the ubiquitin-proteasome pathway. The mutant
protein fails to reach a completely folded conformation that is no
longer a substrate for ubiquitination ("stable B"). Wild type
protein reaches this state with 25% efficiency. In this study the
rabbit reticulocyte lysate with added microsomal membranes has been
used to reproduce the post-translational events in the folding of wild
type and
F508 CFTR. In this system wild type CFTR does not reach the
stable B form if the post-translational temperature is 37 °C,
whereas at 30 °C the behavior of both wild type and mutant proteins
mimics that observed in the cell. Geldanamycin stabilizes
F508 CFTR
with respect to ubiquitination only when added post-translationally.
The interaction of wild type and mutant CFTR with the molecular
chaperones heat shock cognate 70 (hsc70) and heat shock protein 90 (hsp90) has been assessed. Release of wild type protein from hsc70
coincides with the cessation of ubiquitination and formation of stable
B. Geldanamycin immediately prevents the binding of hsp90 to
F508
CFTR, and after a delay releases it from hsc70. Release of mutant
protein from hsc70 also coincides with the formation of stable B
F508 CFTR.
Present address: Dept. of Cardiovascular Research, The Rayne
Inst., St. Thomas' Hospital, Lambeth Palace Rd., London SE1 7EH, UK.
Tel.: 44 20 7928 9292 (ext. 2749); Fax: 44 20 7928 0658; E-mail: will.fuller@kcl.ac.uk.
§
To whom correspondence should be addressed: Dept. of Medicine,
Level 5 (Box 157), Addenbrooke's Hospital, Hills Rd.,
Cambridge CB2 2QQ, UK. Tel.: 44 1223 336853; Fax: 44 1223 336846;
E-mail: awc1000@cam.ac.uk.
This article has been cited by other articles:
![]() |
C. Norez, F. Bilan, A. Kitzis, Y. Mettey, and F. Becq Proteasome-Dependent Pharmacological Rescue of Cystic Fibrosis Transmembrane Conductance Regulator Revealed by Mutation of Glycine 622 J. Pharmacol. Exp. Ther., April 1, 2008; 325(1): 89 - 99. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. R. Ramos, A. J. Swanson, and J. Bass Calreticulin and Hsp90 stabilize the human insulin receptor and promote its mobility in the endoplasmic reticulum PNAS, June 19, 2007; 104(25): 10470 - 10475. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Xu, C. Liu, J. C. Clark, and J. A. Whitsett Functional Genomic Responses to Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) and CFTR{Delta}508 in the Lung J. Biol. Chem., April 21, 2006; 281(16): 11279 - 11291. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. B. Goldfarb, O. B. Kashlan, J. N. Watkins, L. Suaud, W. Yan, T. R. Kleyman, and R. C. Rubenstein Differential effects of Hsc70 and Hsp70 on the intracellular trafficking and functional expression of epithelial sodium channels PNAS, April 11, 2006; 103(15): 5817 - 5822. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Robben, M. Sze, N.V.A.M. Knoers, and P.M.T. Deen Rescue of Vasopressin V2 Receptor Mutants by Chemical Chaperones: Specificity and Mechanism Mol. Biol. Cell, January 1, 2006; 17(1): 379 - 386. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Oberdorf, D. Pitonzo, and W. R. Skach An Energy-dependent Maturation Step Is Required for Release of the Cystic Fibrosis Transmembrane Conductance Regulator from Early Endoplasmic Reticulum Biosynthetic Machinery J. Biol. Chem., November 18, 2005; 280(46): 38193 - 38202. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. F. Simard, N. D. Daigle, M. J. Bergeron, G. M. Brunet, L. Caron, M. Noel, V. Montminy, and P. Isenring Characterization of a Novel Interaction between the Secretory Na+-K+-Cl- Cotransporter and the Chaperone hsp90 J. Biol. Chem., November 12, 2004; 279(46): 48449 - 48456. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. T. Youker, P. Walsh, T. Beilharz, T. Lithgow, and J. L. Brodsky Distinct Roles for the Hsp40 and Hsp90 Molecular Chaperones during Cystic Fibrosis Transmembrane Conductance Regulator Degradation in Yeast Mol. Biol. Cell, November 1, 2004; 15(11): 4787 - 4797. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Okiyoneda, K. Harada, M. Takeya, K. Yamahira, I. Wada, T. Shuto, M. A. Suico, Y. Hashimoto, and H. Kai {Delta}F508 CFTR Pool in the Endoplasmic Reticulum Is Increased by Calnexin Overexpression Mol. Biol. Cell, February 1, 2004; 15(2): 563 - 574. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Santana, E. Salido, A. Torres, and L. J. Shapiro Primary hyperoxaluria type 1 in the Canary Islands: A conformational disease due to I244T mutation in the P11L-containing alanine:glyoxylate aminotransferase PNAS, June 10, 2003; 100(12): 7277 - 7282. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. R. Choo-Kang and P. L. Zeitlin Induction of HSP70 promotes {Delta}F508 CFTR trafficking Am J Physiol Lung Cell Mol Physiol, July 1, 2001; 281(1): L58 - L68. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Gusarova, A. J. Caplan, J. L. Brodsky, and E. A. Fisher Apoprotein B Degradation Is Promoted by the Molecular Chaperones hsp90 and hsp70 J. Biol. Chem., June 29, 2001; 276(27): 24891 - 24900. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |